Targeting the renin-angiotensin-aldosterone system in fibrosis is a research paper published in Matrix Biology (2020). On theSindex it has a DataRank of 0. It has been cited 185 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R56 HL141165
CIHR
Grant: PJT-162422
American Heart Association
National Institutes of Health
Canadian Institutes of Health Research
FWCI
5.37
Citation Percentile
1.0%
Influential Citations
5
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
Additional file 1 of Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
Additional file 1 of Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
Additional file 1 of Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis